Literature DB >> 20016534

Long-term results of the Israeli National Studies in childhood acute lymphoblastic leukemia: INS 84, 89 and 98.

B Stark, R Nirel, G Avrahami, A Abramov, D Attias, A Ballin, B Bielorai, Y Burstein, H Gavriel, R Elhasid, J Kapelushnik, D Sthoeger, A Toren, M Wientraub, I Yaniv, S Izraeli.   

Abstract

Entities:  

Mesh：

Year:  2009        PMID： 20016534     DOI： 10.1038/leu.2009.254

Source DB:  PubMed          Journal:  Leukemia        ISSN： 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  8 in total

Review 1.  Biology, risk stratification, and therapy of pediatric acute leukemias: an update.

Authors:  Ching-Hon Pui; William L Carroll; Soheil Meshinchi; Robert J Arceci
Journal:  J Clin Oncol       Date:  2011-01-10       Impact factor: 44.544

2.  Pediatric T-cell lymphoblastic leukemia evolves into relapse by clonal selection, acquisition of mutations and promoter hypomethylation.

Authors:  Joachim B Kunz; Tobias Rausch; Obul R Bandapalli; Juliane Eilers; Paulina Pechanska; Stephanie Schuessele; Yassen Assenov; Adrian M Stütz; Renate Kirschner-Schwabe; Jana Hof; Cornelia Eckert; Arend von Stackelberg; Martin Schrappe; Martin Stanulla; Rolf Koehler; Smadar Avigad; Sarah Elitzur; Rupert Handgretinger; Vladimir Benes; Joachim Weischenfeldt; Jan O Korbel; Martina U Muckenthaler; Andreas E Kulozik
Journal:  Haematologica       Date:  2015-08-20       Impact factor: 9.941

3.  Dose intensification of methotrexate and cytarabine during intensified continuation chemotherapy for high-risk B-precursor acute lymphoblastic leukemia: POG 9406: a report from the Children's Oncology Group.

Authors:  Richard L Tower; Tamekia L Jones; Bruce M Camitta; Barbara L Asselin; Beverly A Bell; Allen Chauvenet; Meenakshi Devidas; Edward C Halperin; Jeanette Pullen; Jonathan J Shuster; Naomi Winick; Joanne Kurtzberg
Journal:  J Pediatr Hematol Oncol       Date:  2014-07       Impact factor: 1.289

4.  Second malignant neoplasms after treatment of childhood acute lymphoblastic leukemia.

Authors:  Kjeld Schmiegelow; Mette Frandsen Levinsen; Andishe Attarbaschi; Andre Baruchel; Meenakshi Devidas; Gabriele Escherich; Brenda Gibson; Christiane Heydrich; Keizo Horibe; Yasushi Ishida; Der-Cherng Liang; Franco Locatelli; Gérard Michel; Rob Pieters; Caroline Piette; Ching-Hon Pui; Susana Raimondi; Lewis Silverman; Martin Stanulla; Batia Stark; Naomi Winick; Maria Grazia Valsecchi
Journal:  J Clin Oncol       Date:  2013-05-20       Impact factor: 44.544

Review 5.  Systematic review and meta-analysis of randomized trials of central nervous system directed therapy for childhood acute lymphoblastic leukemia.

Authors:  Sue Richards; Ching-Hon Pui; Paul Gayon
Journal:  Pediatr Blood Cancer       Date:  2012-06-12       Impact factor: 3.167

6.  The evolution of clinical trials for infant acute lymphoblastic leukemia.

Authors:  R S Kotecha; N G Gottardo; U R Kees; C H Cole
Journal:  Blood Cancer J       Date:  2014-04-11       Impact factor: 11.037

7.  Acute lymphoblastic leukemia in children with Down syndrome: a retrospective analysis from the Ponte di Legno study group.

Authors:  Trudy D Buitenkamp; Shai Izraeli; Martin Zimmermann; Erik Forestier; Nyla A Heerema; Marry M van den Heuvel-Eibrink; Rob Pieters; Carin M Korbijn; Lewis B Silverman; Kjeld Schmiegelow; Der-Cheng Liang; Keizo Horibe; Maurizio Arico; Andrea Biondi; Giuseppe Basso; Karin R Rabin; Martin Schrappe; Gunnar Cario; Georg Mann; Maria Morak; Renate Panzer-Grümayer; Veerle Mondelaers; Tim Lammens; Hélène Cavé; Batia Stark; Ithamar Ganmore; Anthony V Moorman; Ajay Vora; Stephen P Hunger; Ching-Hon Pui; Charles G Mullighan; Atsushi Manabe; Gabriele Escherich; Jerzy R Kowalczyk; James A Whitlock; C Michel Zwaan
Journal:  Blood       Date:  2013-11-12       Impact factor: 22.113

8.  Optimizing therapy in the modern age: differences in length of maintenance therapy in acute lymphoblastic leukemia.

Authors:  David T Teachey; Stephen P Hunger; Mignon L Loh
Journal:  Blood       Date:  2021-01-14       Impact factor: 22.113
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.